Expandable metal stents for malignant hilar biliary obstruction

Gastrointestinal Endoscopy Clinics of North America

Volumn 21, Issue 3, 2011, Pages 481-497

  Gerges, Christian ^a   Schumacher, Brigitte ^a   Terheggen, Grischa ^a   Neuhaus, Horst ^a  

^a Children s Hospital   (Germany)

Author keywords

Biliary metal stent; Endoscopic treatment; Hilar obstruction; Malignant biliary obstruction

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; GEMCITABINE; NITINOL; PHOTOFRIN;

ALTERNATIVE MEDICINE; BILE DUCT CANCER; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY DECOMPRESSION; BILIARY TRACT DRAINAGE; BILIARY TRACT SURGERY; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHOLANGIOGRAPHY; CHOLANGITIS; COMPARATIVE STUDY; ENDOPROSTHESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; HUMAN; IMPLANTATION; LIVER FUNCTION; MAGNETIC RESONANCE CHOLANGIOPANCREATICOGRAPHY; MALIGNANT HILAR BILIARY OBSTRUCTION; PALLIATIVE THERAPY; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHIC DRAINAGE; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PRIORITY JOURNAL; REVIEW; SELF EXPANDABLE METAL STENT; STENOSIS; STENT; SURVIVAL; VASCULAR PATENCY;

BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CHOLESTASIS; CONSTRICTION, PATHOLOGIC; HUMANS; JAUNDICE, OBSTRUCTIVE; METALS; STENTS;

EID: 79959194610     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2011.04.004     Document Type: Review

References (91)

1. Larghi A., Tringali A., Lecca P.G., et al. Management of hilar biliary strictures. Am J Gastroenterol 2008, 103:458-473.
2. Khan S.A., Taylor-Robinson S.D., Toledano M.B., et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002, 37:806-813.
3. Vauthey J.N., Blumgart L.H. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994, 14:109-114.
4. Singh P., Patel T. Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Curr Opin Gastroenterol 2006, 22:294-299.
5. Bloom C.M., Langer B., Wilson S.R. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 1999, 19:1199-1218.
6. Lee J.H., Yang H.M., Bak U.B., et al. Promoting role of Clonorchis sinensis infection on induction of cholangiocarcinoma during two-step carcinogenesis. Korean J Parasitol 1994, 32:13-18.
7. Okuda K., Nakanuma Y., Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 2002, 17:1049-1055.
8. Donato F., Gelatti U., Tagger A., et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001, 12:959-964.
9. Chen M.F., Jan Y.Y., Wang C.S., et al. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer 1993, 71:2461-2465.
10. Chow L.T., Ahuja A.T., Kwong K.H., et al. Mucinous cholangiocarcinoma: an unusual complication of hepatolithiasis and recurrent pyogenic cholangitis. Histopathology 1997, 30:491-494.
11. Chang K.Y., Chang J.Y., Yen Y. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Canc Netw 2009, 7:423-427.
12. Levi S., Urbano-Ispizua A., Gill R., et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991, 51:3497-3502.
13. Okuda K., Nakanuma Y., Miyazaki M. Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment. J Gastroenterol Hepatol 2002, 17:1056-1063.
14. Khan S.A., Thomas H.C., Toledano M.B., et al. p53 Mutations in human cholangiocarcinoma: a review. Liver Int 2005, 25:704-716.
15. Khan S.A., Thomas H.C., Davidson B.R., et al. Cholangiocarcinoma. Lancet 2005, 366:1303-1314.
16. van Leeuwen D.J., Reeders J.W. Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann Oncol 1999, 10(Suppl 4):89-93.
17. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996, 224:463-473. [discussion: 473-5].
18. Meyer D.G., Weinstein B.J. Klatskin tumors of the bile ducts: sonographic appearance. Radiology 1983, 148:803-804.
19. Su C.H., Shyr Y.M., Lui W.Y., et al. Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 1997, 84:969-973.
20. The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg 1989, 19:98-129.
21. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965, 38:241-256.
22. Bismuth H., Corlette M.B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975, 140:170-178.
23. Bismuth H., Castaing D., Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988, 12:39-47.
24. De Bellis M., Sherman S., Fogel E.L., et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc 2002, 56:552-561.
25. Chahal P., Baron T.H. Endoscopic palliation of cholangiocarcinoma. Curr Opin Gastroenterol 2006, 22:551-560.
26. Tsuyuguchi T., Fukuda Y., Saisho H. Peroral cholangioscopy for the diagnosis and treatment of biliary diseases. J Hepatobiliary Pancreat Surg 2006, 13:94-99.
27. DeWitt J., Misra V.L., Leblanc J.K., et al. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc 2006, 64:325-333.
28. Baron T.H. Palliation of malignant obstructive jaundice. Gastroenterol Clin North Am 2006, 35:101-112.
29. Jarnagin W.R., Fong Y., DeMatteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001, 234:507-517. [discussion: 517-9].
30. Prat F., Chapat O., Ducot B., et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998, 47:1-7.
31. Singhal D., van Gulik T.M., Gouma D.J. Palliative management of hilar cholangiocarcinoma. Surg Oncol 2005, 14:59-74.
32. Ducreux M., Liguory C., Lefebvre J.F., et al. Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 1992, 37:778-783.
33. Liu C.L., Lo C.M., Lai E.C., et al. Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg 1998, 133:293-296.
34. Lee S.H., Park J.K., Yoon W.J., et al. Optimal biliary drainage for inoperable Klatskin's tumor based on Bismuth type. World J Gastroenterol 2007, 13:3948-3955.
35. Hintze R.E., Abou-Rebyeh H., Adler A., et al. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001, 53:40-46.
36. Freeman M.L., Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 2003, 58:41-49.
37. Paik W.H., Park Y.S., Hwang J.H., et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2009, 69:55-62.
38. Charton J.P., Shim C., Neuhaus H. Percutaneous transhepatic cholangiography and cholangioskopy. Gastroenterological endoscopy 2010, 167-176. Thieme, New York. 2nd edition. M. Classen, G.N.J. Tytgat, C.J. Lightdale (Eds.).
39. Itoi T., Neuhaus H., Chen Y.K. Diagnostic value of image-enhanced video cholangiopancreatoscopy. Gastrointest Endosc Clin N Am 2009, 19:557-566.
40. Seo D.W., Kim M.H., Lee S.K., et al. Usefulness of cholangioscopy in patients with focal stricture of the intrahepatic duct unrelated to intrahepatic stones. Gastrointest Endosc 1999, 49:204-209.
41. Chang W.H., Kortan P., Haber G.B. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998, 47:354-362.
42. Motte S., Deviere J., Dumonceau J.M., et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991, 101:1374-1381.
43. Kaassis M., Boyer J., Dumas R., et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003, 57:178-182.
44. Libby E.D., Leung J.W. Prevention of biliary stent clogging: a clinical review. Am J Gastroenterol 1996, 91:1301-1308.
45. Terruzzi V., Comin U., De Grazia F., et al. Prospective randomized trial comparing Tannenbaum Teflon and standard polyethylene stents in distal malignant biliary stenosis. Gastrointest Endosc 2000, 51:23-27.
46. Costamagna G., Mutignani M., Rotondano G., et al. Hydrophilic hydromer-coated polyurethane stents versus uncoated stents in malignant biliary obstruction: a randomized trial. Gastrointest Endosc 2000, 51:8-11.
47. Catalano M.F., Geenen J.E., Lehman G.A., et al. " Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture. Gastrointest Endosc 2002, 55:354-358.
48. Peters R.A., Williams S.G., Lombard M., et al. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy 1997, 29:10-16.
49. Cheng J.L., Bruno M.J., Bergman J.J., et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002, 56:33-39.
50. Cipolletta L., Rotondano G., Marmo R., et al. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review. Dig Liver Dis 2007, 39:375-388.
51. Schmassmann A., von Gunten E., Knuchel J., et al. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996, 91:654-659.
52. Soderlund C., Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 2006, 63:986-995.
53. Loew B.J., Howell D.A., Sanders M.K., et al. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc 2009, 70:445-453.
54. Neuhaus H., Gottlieb K., Classen M. The " stent through wire mesh technique" for complicated biliary strictures. Gastrointest Endosc 1993, 39:553-556.
55. Suk K.T., Kim J.W., Kim H.S., et al. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. Gastrointest Endosc 2007, 66:798-803.
56. Rowinsky E.K., Donehower R.C. Paclitaxel (taxol). N Engl J Med 1995, 332:1004-1014.
57. Lee S.S., Shin J.H., Han J.M., et al. Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model. Gastrointest Endosc 2009, 69:1140-1147.
58. Inal M., Akgul E., Aksungur E., et al. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 2003, 14:1409-1416.
59. Vienne A., Hobeika E. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc 2010, 72:728-735.
60. Naitoh I., Ohara H., Nakazawa T., et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J Gastroenterol Hepatol 2009, 24:552-557.
61. Park do H., Lee S.S., Moon J.H., et al. Newly designed stent for endoscopic bilateral stent-in-stent placement of metallic stents in patients with malignant hilar biliary strictures: multicenter prospective feasibility study (with videos). Gastrointest Endosc 2009, 69:1357-1360.
62. Rey J.F., Dumas R., Canard J.M., et al. Guidelines of the French Society of Digestive Endoscopy: biliary stenting. Endoscopy 2002, 34:169-173. 181-5.
63. Perdue D.G., Freeman M.L., DiSario J.A., et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol 2008, 42:1040-1046.
64. Knyrim K., Wagner H.J., Pausch J., et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993, 25:207-212.
65. Bethge N., Wagner H.J., Knyrim K., et al. Technical failure of biliary metal stent deployment in a series of 116 applications. Endoscopy 1992, 24:395-400.
66. Huibregtse K., Carr-Locke D.L., Cremer M., et al. Biliary stent occlusion-a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy 1992, 24:391-394.
67. Raijman I. Biliary and pancreatic stents. Gastrointest Endosc Clin N Am 2003, 13:561-592. vii-viii.
68. Davids P.H., Groen A.K., Rauws E.A., et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992, 340:1488-1492.
69. Donelli G., Guaglianone E., Di Rosa R., et al. Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res 2007, 5:53-60.
70. Ell C., Fleig W.E., Hochberger J. Broken biliary metal stent after repeated electrocoagulation for tumor ingrowth. Gastrointest Endosc 1992, 38:197-199.
71. Cremer M., Deviere J., Sugai B., et al. Expandable biliary metal stents for malignancies: endoscopic insertion and diathermic cleaning for tumor ingrowth. Gastrointest Endosc 1990, 36:451-457.
72. Tham T.C., Carr-Locke D.L., Vandervoort J., et al. Management of occluded biliary Wallstents. Gut 1998, 42:703-707.
73. Lossef S.V., Druy E., Jelinger E., et al. Use of hot-tip laser probes to recanalize occluded expandable metallic biliary endoprostheses. AJR Am J Roentgenol 1992, 158:199-201.
74. Rogart J.N., Boghos A., Rossi F., et al. Analysis of endoscopic management of occluded metal biliary stents at a single tertiary care center. Gastrointest Endosc 2008, 68:676-682.
75. Familiari P., Bulajic M., Mutignani M., et al. Endoscopic removal of malfunctioning biliary self-expandable metallic stents. Gastrointest Endosc 2005, 62:903-910.
76. Levy M.J., Wiersema M.J. Endoscopic removal of a biliary Wallstent with a suture-cutting device in a patient with primary pancreatic lymphoma. Endoscopy 2002, 34:835-837.
77. Matsushita M., Takakuwa H., Nishio A., et al. Open-biopsy-forceps technique for endoscopic removal of distally migrated and impacted biliary metallic stents. Gastrointest Endosc 2003, 58:924-927.
78. Shin H.P., Kim M.H., Jung S.W., et al. Endoscopic removal of biliary self-expandable metallic stents: a prospective study. Endoscopy 2006, 38:1250-1255.
79. Kahaleh M., Tokar J., Le T., et al. Removal of self-expandable metallic Wallstents. Gastrointest Endosc 2004, 60:640-644.
80. Kundu R., Pleskow D. Biliary and pancreatic stents: complications and management. Tech Gastrointest Endosc 2007, 9:125-134.
81. Iwatsuki S., Todo S., Marsh J.W., et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998, 187:358-364.
82. Meyer C.G., Penn I., James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000, 69(8):1633-1637.
83. Robles R., Figueras J., Turrion V.S., et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004, 239:265-271.
84. Rea D.J., Heimbach J.K., Rosen C.B., et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005, 242:451-458. [discussion: 458-61].
85. Bruha R., Petrtyl J., Kubecova M., et al. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies-the question of long-term palliation. Hepatogastroenterology 2001, 48:631-637.
86. Kubota Y., Takaoka M., Kin H., et al. Endoscopic irradiation and parallel arrangement of Wallstents for hilar cholangiocarcinoma. Hepatogastroenterology 1998, 45:415-419.
87. Morganti A.G., Trodella L., Valentini V., et al. Combined modality treatment in unresectable extrahepatic biliary carcinoma. Int J Radiat Oncol Biol Phys 2000, 46:913-919.
88. Berr F., Tannapfel A., Lamesch P., et al. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol 2000, 32:352-357.
89. Kahaleh M., Mishra R., Shami V.M., et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol 2008, 6:290-297.
90. Ortner M.E., Caca K., Berr F., et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003, 125:1355-1363.
91. Zoepf T., Jakobs R., Arnold J.C., et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005, 100:2426-2430.